--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
Tesla
TSLA
US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 1.2600
- 0.00000.00%
Trading Dec 11 14:10 ET
158.51MMarket Cap-6.00P/E (TTM)
1.2982High1.2100Low616.44KVolume1.2900Open1.2600Pre Close769.34KTurnover0.52%Turnover RatioLossP/E (Static)125.80MShares2.310052wk High2.15P/B148.64MFloat Cap0.701352wk Low--Dividend TTM117.97MShs Float2231.9981Historical High--Div YieldTTM7.00%Amplitude0.5000Historical Low1.2480Avg Price1Lot Size
Atossa Therapeutics Key Stats
Atossa Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Atossa Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data